QR Code

Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas

Kidney cancers comprise about 3% of all new malignancies in the United States. Renal cell carcinomas (RCCs) are the most common type of renal malignancy making up about 85% of kidney cancer cases. Signs and symptoms of renal cell carcinomas can result from local tumor growth, paraneoplastic syndrome...

Full description

Saved in:
Main Author: Robert Roskoski, Jr.
Format: Artigo
Language:Inglês
Published: Elsevier 2024-05-01
Series:Pharmacological Research
Subjects:
Avelumab
Bevacizumab
Ipilimumab
Nivolumab
Pembrolizumab
Vasculogenesis
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661824001257
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items